Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 114, Issue 5, Pages (May 1998)

Similar presentations


Presentation on theme: "Volume 114, Issue 5, Pages (May 1998)"— Presentation transcript:

1 Volume 114, Issue 5, Pages 1009-1015 (May 1998)
Circulating xanthine oxidase and neutrophil activation during human liver transplantation  Eero J. Pesonen*, Nina Linder*, Kari O. Raivio*, Annikki Sarnesto*, Risto Lapatto*, Krister Höckerstedt‡, Heikki Mäkisalo‡, Sture Andersson*,§,∥  Gastroenterology  Volume 114, Issue 5, Pages (May 1998) DOI: /S (98)70321-X Copyright © 1998 American Gastroenterological Association Terms and Conditions

2 Fig. 1 The sampling protocol. 0a, after induction of anesthesia; 0b, immediately before the anhepatic period; PV, 5 minutes after portal vein declamping; IVC, 5 minutes after inferior vena cava declamping; and HA, 3 minutes after hepatic artery declamping. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

3 Fig. 2 Plasma concentrations of xanthine oxidase in the pulmonary artery. *P < 0.05, **P < 0.01 vs. 0a. See Figure 1 for abbreviations. Note logarithmic scale. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

4 Fig. 3 Plasma concentration differences of xanthine oxidase between the hepatic vein (HV) and the portal vein (PV). IVC, inferior vena cava; HA, hepatic artery. *P < 0.05, **P < 0.01 HV vs. PV. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

5 Fig. 4 Radial arterial xanthine oxidase protein concentration (○) and activity (●) of 4 patients after induction of anesthesia (0a), immediately before the anhepatic period (0b), and after hepatic artery declamping (HA). Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

6 Fig. 5 Plasma concentrations of hypoxanthine in the pulmonary artery. See Figure 1 for abbreviations. *P < 0.05, **P < 0.01 vs. 0a. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

7 Fig. 6 Plasma concentration differences of hypoxanthine between the hepatic vein (HV) and the portal vein (PV). IVC, inferior vena cava; HA, hepatic artery. *P < 0.05 HV vs. PV. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

8 Fig. 7 Plasma concentrations of xanthine in the pulmonary artery. See Figure 1 for abbreviations. *P < 0.05, **P < 0.01 vs. 0a. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

9 Fig. 8 Plasma concentration differences of xanthine between the hepatic vein (HV) and the portal vein (PV). IVC, inferior vena cava; HA, hepatic artery. *P < 0.05 HV vs. PV. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

10 Fig. 9 Plasma concentrations of lactoferrin in the pulmonary artery. See Figure 1 for abbreviations. *P < 0.05, **P < 0.01 vs. 0a. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions

11 Fig. 10 Plasma concentration differences of lactoferrin between the hepatic vein (HV) and the portal vein (PV). IVC, inferior vena cava; HA, hepatic artery. **P < 0.01 HV vs. PV. Gastroenterology  , DOI: ( /S (98)70321-X) Copyright © 1998 American Gastroenterological Association Terms and Conditions


Download ppt "Volume 114, Issue 5, Pages (May 1998)"

Similar presentations


Ads by Google